Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Coocooburra's Profile
Displaying 1-50 of 404 result(s).
CYDY CytoDyn Inc
08/23/2020 1:45:15 PM
Its here https://www.forbes.com/sit (1)
CYDY CytoDyn Inc
08/07/2020 9:01:21 AM
Really ppl what a useless post. (4)
CYDY CytoDyn Inc
08/05/2020 4:11:44 PM
It is and it isn't a competition. W (2)
CYDY CytoDyn Inc
08/05/2020 2:46:48 PM
I would vote heavily in favor of so (1)
CYDY CytoDyn Inc
08/05/2020 2:29:33 PM
Lenzilumab changed primary endpoint (9)
CYDY CytoDyn Inc
08/04/2020 11:16:32 PM
rlftf phase 2/3 PR. From July. Thei (3)
CYDY CytoDyn Inc
08/04/2020 6:33:56 PM
Ok so they evaluated 14 day endpoin
CYDY CytoDyn Inc
08/04/2020 6:02:27 PM
Could you clarify? I'm sorry but I
CYDY CytoDyn Inc
08/04/2020 12:31:20 PM
Yeah I'm just not seeing a whole lo (3)
CYDY CytoDyn Inc
08/04/2020 11:37:08 AM
Yeah i was on the cc yesterday and (2)
CYDY CytoDyn Inc
08/01/2020 5:10:46 PM
Mortality rate for all eIND patient
CYDY CytoDyn Inc
08/01/2020 2:24:07 PM
Per Dr. P last night, cydy has tens (3)
CYDY CytoDyn Inc
08/01/2020 11:31:59 AM
Last Q asked Dr P last night was ba (5)
CYDY CytoDyn Inc
07/30/2020 8:48:05 PM
What type of narrative can we devel (12)
CYDY CytoDyn Inc
07/30/2020 8:44:15 PM
Correction - Oxygen use and Mech ve (3)
CYDY CytoDyn Inc
07/30/2020 8:12:28 PM
Re-listened to m2m update - Day 3 v (4)
CYDY CytoDyn Inc
07/30/2020 11:47:39 AM
covid cases at all time high in USA (13)
CYDY CytoDyn Inc
07/30/2020 8:55:30 AM
Financing news closes us above 5. A (4)
CYDY CytoDyn Inc
07/29/2020 9:36:05 PM
Meso interim scheduled for Septembe (1)
CYDY CytoDyn Inc
07/23/2020 10:14:55 AM
Will post my complete analysis on S (6)
CYDY CytoDyn Inc
07/23/2020 10:04:26 AM
5/56 experienced SAE in treatment. (11)
CYDY CytoDyn Inc
07/18/2020 10:15:45 AM
Grateful to all the longs here. Hav (11)
CYDY CytoDyn Inc
07/14/2020 8:59:01 AM
Leronlimab doesn't block any virus (1)
CYDY CytoDyn Inc
07/06/2020 6:11:06 PM
so my assumption then is that the a
CYDY CytoDyn Inc
07/06/2020 5:02:57 PM
Can you elaborate? I personally hav
CYDY CytoDyn Inc
07/06/2020 12:08:24 PM
they are not delaying the m2m resul (4)
CYDY CytoDyn Inc
07/06/2020 10:14:29 AM
Doesn't matter as much as it might'
CYDY CytoDyn Inc
07/05/2020 3:59:25 PM
Yes I agree with you on the results (5)
CYDY CytoDyn Inc
07/05/2020 3:06:48 PM
This is gonna be a crazy ass month (3)
CYDY CytoDyn Inc
07/05/2020 3:06:00 PM
In my mind the publication or submi (2)
CYDY CytoDyn Inc
07/05/2020 1:01:32 PM
Yes I meant to say interim for s/c
CYDY CytoDyn Inc
07/05/2020 12:47:56 PM
I had email exchange with NP which (7)
CYDY CytoDyn Inc
07/04/2020 8:04:43 PM
No actemra failed in Italian study
CYDY CytoDyn Inc
07/04/2020 3:07:10 PM
this study is more definitive than (2)
CYDY CytoDyn Inc
07/04/2020 3:03:19 PM
WHO discontinues hydroxychloroquin (2)
CYDY CytoDyn Inc
07/04/2020 9:44:42 AM
The baricitinib /rem trial is categ
CYDY CytoDyn Inc
07/04/2020 8:52:22 AM
From PR Advised the Company, subjec (1)
CYDY CytoDyn Inc
07/03/2020 8:43:36 PM
Guys my bad Leronlimab is on the li
CYDY CytoDyn Inc
07/03/2020 8:19:40 PM
Mavrilimumab Lenzilumab Anakinra Ca (3)
CYDY CytoDyn Inc
07/03/2020 9:44:42 AM
Outcomes for UCLA + other hospital (1)
CYDY CytoDyn Inc
07/03/2020 9:12:18 AM
~15 mortality
CYDY CytoDyn Inc
07/03/2020 9:11:21 AM
~15%
CYDY CytoDyn Inc
07/02/2020 6:48:05 PM
Just my guess - Our m2m p value wil (11)
CYDY CytoDyn Inc
07/01/2020 12:41:56 PM
Anything about interim at work can'
CYDY CytoDyn Inc
07/01/2020 10:32:16 AM
They must know interim results by n
CYDY CytoDyn Inc
06/30/2020 8:58:33 PM
Marked it as an announcement on FB (1)
CYDY CytoDyn Inc
06/29/2020 12:44:08 PM
Sorry I'm trying to put together th
CYDY CytoDyn Inc
06/29/2020 12:12:32 PM
Can you elaborate a little more on
CYDY CytoDyn Inc
06/25/2020 10:31:29 AM
What is happening???? (2)
CYDY CytoDyn Inc
06/25/2020 9:43:22 AM
Idk anything but is this daily incr
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding Housing Trends: The Challenges of Rent Indices
  • Key Economic Indicators and Trade Talks Shape Market Focus
  • Exploring the Innovations of Bitcoin Swift and Its Ecosystem
  • Trump's Golden Dome Initiative: A $151 Billion Defense Game-Changer
  • HashJ Expands Services Amidst XRP's $200 Billion Milestone
  • KEENON Robotics Unveils Next-Gen Humanoid Service Robot
  • Team Insta360 and UAE Team Emirates: A New Era in Cycling
  • Assembly Biosciences Shares Progress on Genital Herpes Treatment
  • Pony AI Inc. Secures Permit for Driverless Robotaxi Services
  • Meta Boosts AI Team with OpenAI Expert Shengjia Zhao
  • Bitget Expands Its Influence in Southeast Asia's Crypto Scene
  • Tesla's Upcoming Shareholder Proposals on xAI Investment Strategies
  • Reckitt Benckiser Investors: Join the Class Action Today!
  • Exploring China's Economic Resilience Amid Global Challenges
  • Investors Alert: Join Class Action Against Reckitt Benckiser
  • Investigation Opportunities for Hims & Hers Health Shareholders
  • Investors Alert: Lawsuit Against Tempus AI Affects Shareholders
  • Investors Urged to Claim Losses in Neogen Corporation Lawsuit
  • Reinforcing Trilateral Environmental Collaboration in North America
  • Mercury Insurance to Extend Homeowners Coverage for Californians
  • Klotho Neurosciences, Inc. Innovates for Healthy Aging and Longevity
  • Flywire Corporation Faces Class Action: All You Need to Know
  • Understanding the Easterly ROCMuni Fund Class Action: Key Insights
  • Arnold & Itkin Takes Legal Action Against Chevron Over Explosion
  • Paul Mueller Company Revamps Earnings Report for 2025
  • Westbridge Renewable Energy's Strategic Share Consolidation Details
  • Investigation into Data Breach Claims for Tea App Users
  • Traction Uranium Secures Funding of Up to C$833,400 for Expansion
  • Diginex Moves Forward with Bonus Shares and Shareholder Decisions
  • Faircourt Asset Management Details July Fund Distribution
  • Unveiling Investigations into Crocs, Inc. Stockholder Rights
  • Essential Guide to Enjoying Summer with CASEKOO's Magic Stand
  • Nutex Health Faces Scrutiny After Blue Orca Capital Report
  • Caribou Biosciences Explores Legal Options for Shareholders
  • Chipotle Faces Legal Scrutiny: What Investors Should Know
  • The Growth of $100 in Danaher Corporation Over the Years
  • Unveiling The Stunning Growth of Tesla's Stock Value
  • Black Pearl Equities Initiates Tender Offer for Regional Health Shares
  • ISS Endorses Merger Between Regional Health Properties and SunLink
  • Grupo Bafar Reports Strong Second Quarter Performance in 2025
  • Black Pearl Equities Expands Investment Opportunities for RHEP Shares
  • Investor Alert: Atkore Inc. Under Investigation for Misconduct
  • Legal Investigation Announced for Acadia Healthcare Stockholders
  • Transforming $1000 in RTX into a Profitable Investment Journey
  • Investors Have Chance to Participate in Luminar Lawsuit
  • Exploring Devon Energy's Stock Growth Over Five Years
  • Lombard Street Capital and Lithium Africa's Strategic Merger
  • A Look at Reinsurance Group's Remarkable Growth Over 5 Years
  • Understanding Investor Rights Amid Semler Scientific Disputes
  • Insights into Tungray Technologies Inc and Investor Rights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site